ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

ACS Courage award Goes To Polhill, Former Beirut Hostage

March 29, 1991

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002